In this study, we analysed LOX expression separately either in the cytoplasm, or in the nucleus, in a series of rectal cancer specimens from the patients participating in a randomized Swedish rectal cancer trial of preoperative radiotherapy (RT) with long-term follow up data [21, 22]. Here, LOX is linked to rectal cancer.